BamSEC and AlphaSense Join Forces
Learn More

APP Pharmaceuticals, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 56 pages Form of Contingent Value Rights Agreement by and Between Fresenius Kabi Pharmaceuticals Holding, LLC and [Trustee] Dated as of , 200
12/34/56
EX-10.1
from 8-K 18 pages Written Consent and Voting Agreement
12/34/56
EX-10.25
from 10-Q 17 pages Employment Agreement
12/34/56
EX-10.9
from 10-K 22 pages Lease Agreement Between APP Pharmaceuticals, LLC and Abraxis Bioscience, LLC Lease Agreement
12/34/56
EX-10.8
from 10-K 22 pages Lease Agreement Between Abraxis Bioscience, LLC and APP Pharmaceuticals, LLC Lease Agreement
12/34/56
EX-10.7
from 10-K 22 pages Lease Agreement Between Abraxis Bioscience, LLC and APP Pharmaceuticals, LLC Lease Agreement
12/34/56
EX-10.6
from 10-K 23 pages Lease Agreement Between Abraxis Bioscience, LLC and APP Pharmaceuticals, LLC Lease Agreement
12/34/56
EX-10.5
from 10-K 42 pages Manufacturing Agreement
12/34/56
EX-10.4
from 10-K 20 pages Employee Matters Agreement
12/34/56
EX-10.3
from 10-K 11 pages Transition Services Agreement
12/34/56
EX-10.2
from 10-K 22 pages Tax Allocation Agreement
12/34/56
EX-10.1
from 8-K 11 pages Agreement and Plan of Reorganization
12/34/56
EX-10.25
from 10-K 11 pages Retention Agreement
12/34/56
EX-10.24
from 10-K 11 pages Retention Agreement
12/34/56
EX-10.21
from 10-Q 16 pages Aircraft Purchase and Sale Agreement
12/34/56
EX-10.20
from 10-Q 72 pages Standard Form Office Lease Between California State Teachers’ Retirement System, a Public Entity, the Landlord, and American Bioscience, Inc., a California Corporation the Tenant Dated: March 24, 2006 for Premises Located at 11755 Wilshire Boulevard Los Angeles, California
12/34/56
EX-10.18
from 10-Q/A 18 pages Marked [***] Have Been Redacted and Have Been Filed Separately With the U.S. Securities and Exchange Commission. Manufacturing and Supply Agreement
12/34/56
EX-10.17
from 10-Q/A 18 pages Marked [***] Have Been Redacted and Have Been Filed Separately With the U.S. Securities and Exchange Commission. Manufacturing and Supply Agreement
12/34/56
EX-10.16
from 10-Q/A 4 pages Agreement
12/34/56
EX-10.15
from 10-Q/A 2 pages Azstazeneca Uk Limited 15 Stanhope Gate London W1k 1ln, England June 28, 2006
12/34/56